GPCR logo

GPCR
Structure Therapeutics Inc - ADR

2,163
Mkt Cap
$2.79B
Volume
732,992.00
52W High
$94.90
52W Low
$15.80
PE Ratio
-14.56
GPCR Fundamentals
Price
$39.19
Prev Close
$38.79
Open
$39.20
50D MA
$46.31
Beta
0.89
Avg. Volume
961,776.38
EPS (Annual)
-$2.39
P/B
1.92
Rev/Employee
$0.00
$2,677.55
Loading...
Loading...

About

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
220

Frequently Asked Questions

What is Market Cap of Structure Therapeutics Inc - ADR?
What is the 52-week high for Structure Therapeutics Inc - ADR?
What is the 52-week low for Structure Therapeutics Inc - ADR?
What is Structure Therapeutics Inc - ADR stock price today?
What was Structure Therapeutics Inc - ADR stock price yesterday?
What is the PE ratio of Structure Therapeutics Inc - ADR?
What is the Price-to-Book ratio of Structure Therapeutics Inc - ADR?
What is the 50-day moving average of Structure Therapeutics Inc - ADR?
How many employees does Structure Therapeutics Inc - ADR have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available